Spotlight Asset Group Inc. grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 54.2% in the 2nd quarter, Holdings Channel.com reports. The firm owned 782 shares of the healthcare conglomerate’s stock after purchasing an additional 275 shares during the quarter. Spotlight Asset Group Inc.’s holdings in UnitedHealth Group were worth $376,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Bank Julius Baer & Co. Ltd Zurich raised its holdings in UnitedHealth Group by 97,436.9% during the second quarter. Bank Julius Baer & Co. Ltd Zurich now owns 1,029,274,230 shares of the healthcare conglomerate’s stock valued at $494,710,366,000 after acquiring an additional 1,028,218,963 shares during the period. BlackRock Inc. increased its stake in UnitedHealth Group by 0.7% in the 1st quarter. BlackRock Inc. now owns 74,928,539 shares of the healthcare conglomerate’s stock worth $35,410,478,000 after acquiring an additional 509,633 shares during the last quarter. Wellington Management Group LLP raised its position in shares of UnitedHealth Group by 0.6% during the 1st quarter. Wellington Management Group LLP now owns 24,079,140 shares of the healthcare conglomerate’s stock valued at $11,379,561,000 after buying an additional 140,312 shares in the last quarter. Geode Capital Management LLC raised its holdings in UnitedHealth Group by 1.4% during the 1st quarter. Geode Capital Management LLC now owns 17,101,395 shares of the healthcare conglomerate’s stock valued at $8,063,262,000 after buying an additional 242,959 shares during the period. Finally, Morgan Stanley raised its position in UnitedHealth Group by 13.8% in the 4th quarter. Morgan Stanley now owns 15,635,038 shares of the healthcare conglomerate’s stock worth $8,289,386,000 after purchasing an additional 1,893,192 shares during the period. Hedge funds and other institutional investors own 85.69% of the company’s stock.
Analyst Ratings Changes
Several research firms recently commented on UNH. HSBC started coverage on shares of UnitedHealth Group in a research note on Wednesday, September 6th. They issued a “hold” rating and a $540.00 price target on the stock. TD Cowen decreased their price objective on UnitedHealth Group from $562.00 to $555.00 and set an “outperform” rating for the company in a research note on Monday, July 17th. Piper Sandler upped their price target on UnitedHealth Group from $580.00 to $584.00 and gave the stock an “overweight” rating in a research report on Monday, October 16th. Sanford C. Bernstein upgraded UnitedHealth Group from a “market perform” rating to an “outperform” rating and increased their price target for the company from $595.00 to $603.00 in a research note on Tuesday, July 18th. Finally, Stephens reiterated an “overweight” rating and set a $560.00 price target on shares of UnitedHealth Group in a research note on Friday, August 11th. Two investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $578.30.
Insider Buying and Selling at UnitedHealth Group
In other UnitedHealth Group news, EVP Erin Mcsweeney sold 4,498 shares of the company’s stock in a transaction dated Monday, October 16th. The shares were sold at an average price of $544.28, for a total value of $2,448,171.44. Following the transaction, the executive vice president now directly owns 9,218 shares in the company, valued at approximately $5,017,173.04. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In related news, Director Stephen J. Hemsley sold 121,515 shares of the stock in a transaction on Tuesday, October 17th. The stock was sold at an average price of $540.58, for a total value of $65,688,578.70. Following the transaction, the director now directly owns 521,818 shares of the company’s stock, valued at approximately $282,084,374.44. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Erin Mcsweeney sold 4,498 shares of the business’s stock in a transaction that occurred on Monday, October 16th. The stock was sold at an average price of $544.28, for a total transaction of $2,448,171.44. Following the sale, the executive vice president now owns 9,218 shares of the company’s stock, valued at $5,017,173.04. The disclosure for this sale can be found here. 0.35% of the stock is owned by insiders.
UnitedHealth Group Trading Down 0.0 %
Shares of UnitedHealth Group stock opened at $541.00 on Monday. UnitedHealth Group Incorporated has a 1-year low of $445.68 and a 1-year high of $553.00. The stock’s 50 day simple moving average is $513.54 and its 200-day simple moving average is $496.83. The stock has a market cap of $500.38 billion, a P/E ratio of 23.49, a P/E/G ratio of 1.64 and a beta of 0.63. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.80 and a quick ratio of 0.80.
UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its quarterly earnings results on Friday, October 13th. The healthcare conglomerate reported $6.56 EPS for the quarter, topping the consensus estimate of $6.33 by $0.23. The business had revenue of $92.36 billion during the quarter, compared to the consensus estimate of $91.41 billion. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.58%. The company’s quarterly revenue was up 14.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $5.79 earnings per share. Analysts predict that UnitedHealth Group Incorporated will post 24.94 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Monday, December 4th will be given a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.39%. The ex-dividend date of this dividend is Friday, December 1st. UnitedHealth Group’s dividend payout ratio is currently 32.64%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
- Five stocks we like better than UnitedHealth Group
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Can new GPT store spur generative AI monetization?
- Bank Stocks – Best Bank Stocks to Invest In
- Energy looks to dominate markets with 3 oil and gas stocks
- Large Cap Stock Definition and How to Invest
- Microsoft hits record highs as market impact strengthens
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.